Cargando…

Advances in Parkinson’s Disease Drugs

Detalles Bibliográficos
Autores principales: Di Stefano, Antonio, Marinelli, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615848/
https://www.ncbi.nlm.nih.gov/pubmed/34827638
http://dx.doi.org/10.3390/biom11111640
_version_ 1784604204740902912
author Di Stefano, Antonio
Marinelli, Lisa
author_facet Di Stefano, Antonio
Marinelli, Lisa
author_sort Di Stefano, Antonio
collection PubMed
description
format Online
Article
Text
id pubmed-8615848
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86158482021-11-26 Advances in Parkinson’s Disease Drugs Di Stefano, Antonio Marinelli, Lisa Biomolecules Editorial MDPI 2021-11-05 /pmc/articles/PMC8615848/ /pubmed/34827638 http://dx.doi.org/10.3390/biom11111640 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Di Stefano, Antonio
Marinelli, Lisa
Advances in Parkinson’s Disease Drugs
title Advances in Parkinson’s Disease Drugs
title_full Advances in Parkinson’s Disease Drugs
title_fullStr Advances in Parkinson’s Disease Drugs
title_full_unstemmed Advances in Parkinson’s Disease Drugs
title_short Advances in Parkinson’s Disease Drugs
title_sort advances in parkinson’s disease drugs
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615848/
https://www.ncbi.nlm.nih.gov/pubmed/34827638
http://dx.doi.org/10.3390/biom11111640
work_keys_str_mv AT distefanoantonio advancesinparkinsonsdiseasedrugs
AT marinellilisa advancesinparkinsonsdiseasedrugs